Chronic inflammation in asthma: A contest of persistence vs resolution

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 9, 2008, Pages 1095-1109

  Van Hove, C L ^a,b   Maes, T ^a   Joos, G F ^a   Tournoy, K G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Asthma; Chronic inflammation; Endogenous anti inflammatory mediators; Resolution

Indexed keywords

ANTIOXIDANT; CD59 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE; CLARA CELL PROTEIN; CYTOKINE; ENZYME; GALECTIN; GAMMA INTERFERON; HORMONE; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; LIPID; LIPOXIN; NEUROPEPTIDE; NUCLEOLIN; OSTEOPONTIN; PLASMA PROTEIN; PROSTAGLANDIN; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ASTHMA; CHRONIC INFLAMMATION; DISEASE EXACERBATION; EOSINOPHILIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; TH2 CELL;

ANIMALS; ASTHMA; CHRONIC DISEASE; EOSINOPHILIA; HUMANS; INFLAMMATION;

EID: 49349083198     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01772.x     Document Type: Review

References (150)

1. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002 2: 787 795.
2. Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution? Int J Exp Pathol 2007 88: 85 94.
3. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007 21: 325 332.
4. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005 6: 1191 1197.
5. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007 447: 869 874.
6. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007 28: 176 183.
7. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007 25: 101 137.
8. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006 129: 1673 1682.
9. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000 407: 784 788.
10. Bellingan GJ, Xu P, Cooksley H, Cauldwell H, Shock A, Bottoms S et al. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med 2002 196: 1515 1521.
11. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 1996 157: 2577 2585.
12. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001 344: 350 362.
13. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000 161: 1720 1745.
14. Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001 56: 823 826.
15. Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004 1: 93 98.
16. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004 199: 1567 1575.
17. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004 363: 608 615.
18. Larche M. Regulatory T cells in allergy and asthma. Chest 2007 132: 1007 1014.
19. Tournoy KG, Provoost S, Van Hove C, Joos G. The role of immune tolerance in asthma pathogenesis. Curr Allergy Asthma Rep 2006 6: 437 443.
20. Zosky GR, Sly PD. Animal models of asthma. Clin Exp Allergy 2007 37: 973 988.
21. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002 27: 267 272.
22. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004 169: 378 385.
23. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998 53: 849 856.
24. Niu N, Le Goff MK, Li F, Rahman M, Homer RJ, Cohn L. A novel pathway that regulates inflammatory disease in the respiratory tract. J Immunol 2007 178: 3846 3855.
25. Strickland DH, Stumbles PA, Zosky GR, Subrata LS, Thomas JA, Turner DJ et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J Exp Med 2006 203: 2649 2660.
26. Lamb JP, James A, Carroll N, Siena L, Elliot J, Vignola AM. Reduced apoptosis of memory T-cells in the inner airway wall of mild and severe asthma. Eur Respir J 2005 26: 265 270.
27. Tournoy KG, Hove C, Grooten J, Moerloose K, Brusselle GG, Joos GF. Animal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma? Clin Exp Allergy 2006 36: 8 20.
28. Barnes PJ. Cytokine modulators as novel therapies for airway disease. Eur Respir J Suppl 2001 34: 67s 77s.
29. Hawrylowicz CM. Regulatory T cells and IL-10 in allergic inflammation. J Exp Med 2005 202: 1459 1463.
30. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33: 1205 1214.
31. Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005 202: 1539 1547.
32. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19: 683 765.
33. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999 14: 309 314.
34. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998 158: 1958 1962.
35. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003 55: 241 269.
36. Tilg H, Van MC, Van den EA, Kaser A, Van Deventer SJ, Schreiber S et al. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002 50: 191 195.
37. Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology 2000 119: 1461 1472.
38. Wan YY, Flavell RA. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 2007 220: 199 213.
39. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003 113: 685 700.
40. Wan YY, Flavell RA. Regulatory T cells, transforming growth factor-beta, and immune suppression. Proc Am Thorac Soc 2007 4: 271 276.
41. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 198: 1875 1886.
42. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007 120: 227 235.
43. Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Immunol 2005 35: 198 206.
44. Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, Ra C et al. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med 2000 192: 151 158.
45. Fattouh R, Midence G, Arias K, Johnson JR, Walker TD, Goncharova S et al. TGF-{beta} regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008 177: 593 603.
46. Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J et al. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004 169: 214 219.
47. Kitani A, Fuss I, Nakamura K, Kumaki F, Usui T, Strober W. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J Exp Med 2003 198: 1179 1188.
48. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006 27: 208 229.
49. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006 203: 2715 2725.
50. Sergejeva S, Ivanov S, Lotvall J, Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol 2005 33: 248 253.
51. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003 28: 42 50.
52. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005 6: 1133 1141.
53. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007 120: 247 254.
54. Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007 13: 570 578.
55. Kohan M, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy 2007 37: 1444 1454.
56. Chen LC, Zhang Z, Myers AC, Huang SK. Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa protein. J Immunol 2001 167: 3025 3028.
57. Hung CH, Chen LC, Zhang Z, Chowdhury B, Lee WL, Plunkett B et al. Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. J Allergy Clin Immunol 2004 114: 664 670.
58. Yang KD, Ou CY, Chang JC, Chen RF, Liu CA, Liang HM et al. Infant frequent wheezing correlated to Clara cell protein 10 (CC10) polymorphism and concentration, but not allergy sensitization, in a perinatal cohort study. J Allergy Clin Immunol 2007 120: 842 848.
59. Laing IA, Goldblatt J, Eber E, Hayden CM, Rye PJ, Gibson NA et al. A polymorphism of the CC16 gene is associated with an increased risk of asthma. J Med Genet 1998 35: 463 467.
60. Kaiser L, Gronlund H, Sandalova T, Ljunggren HG, Van Hage-Hamsten M, Achour A et al. The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem 2003 278: 37730 37735.
61. Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 2007 179: 4415 4423.
62. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 2008 180: 2752 2756.
63. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450: 566 569.
64. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001 1: 108 116.
65. Yamashita N, Tashimo H, Matsuo Y, Ishida H, Yoshiura K, Sato K et al. Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model. J Allergy Clin Immunol 2006 117: 1040 1046.
66. Worbs T, Forster R. A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol 2007 28: 274 280.
67. Rubinstein N, Ilarregui JM, Toscano MA, Rabinovich GA. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 2004 64: 1 12.
68. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 2004 165: 2045 2053.
69. Lopez E, del Pozo V, Miguel T, Sastre B, Seoane C, Civantos E et al. Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 2006 176: 1943 1950.
70. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, Shinonaga R et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 2007 176: 27 35.
71. Yamamoto H, Kashio Y, Shoji H, Shinonaga R, Yoshimura T, Nishi N et al. Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol 2007 143 (Suppl. 1 95 105.
72. Edwan JH, Perry G, Talmadge JE, Agrawal DK. Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation. J Immunol 2004 172: 5016 5023.
73. Edwan JH, Agrawal DK. Flt3-ligand plasmid prevents the development of pathophysiological features of chronic asthma in a mouse model. Immunol Res 2007 37: 147 159.
74. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001 98: 3520 3526.
75. Tillie-Leblond I, Gosset P, Le BR, Janin A, Prangere T, Tonnel AB et al. Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats. Eur Respir J 2007 30: 31 39.
76. Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007 30: 980 992.
77. Bonnans C, Levy BD. Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am J Respir Cell Mol Biol 2006 36: 201 206.
78. Peters-Golden M. 'Good' lipids for asthma. Nat Med 2002 8: 931 932.
79. Bonnans C, Chanez P, Chavis C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004 59: 1027 1041.
80. Levy BD, Lukacs NW, Berlin AA, Schmidt B, Guilford WJ, Serhan CN et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 2007 21: 3877 3884.
81. Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007 178: 496 502.
82. Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008 367: 509 515.
83. Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, Hoogsteden HC et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007 204: 357 367.
84. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004 25: 40 46.
85. Pavord ID, Wong CS, Williams J, Tattersfield AE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1993 148: 87 90.
86. Jaffar Z, Ferrini ME, Buford MC, Fitzgerald GA, Roberts K. Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma. J Immunol 2007 179: 6193 6203.
87. Idzko M, Hammad H, Van NM, Kool M, Vos N, Hoogsteden HC et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 2007 117: 464 472.
88. Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Eur J Pharmacol 2006 533: 101 109.
89. Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007 28: 551 558.
90. Woerly G, Honda K, Loyens M, Papin JP, Auwerx J, Staels B et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003 198: 411 421.
91. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Lee HK et al. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J Immunol 2006 177: 5248 5257.
92. Voice JK, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul Pept 2002 109: 199 208.
93. Hamidi SA, Szema AM, Lyubsky S, Dickman KG, Degene A, Mathew SM et al. Clues to VIP function from knockout mice. Ann N Y Acad Sci 2006 1070: 5 9.
94. Szema AM, Hamidi SA, Lyubsky S, Dickman KG, Mathew S, Bdel-Razek T et al. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 2006 291: L880 L886.
95. Sergejeva S, Hoshino H, Yoshihara S, Kashimoto K, Lotvall J, Linden A. A synthetic VIP peptide analogue inhibits neutrophil recruitment in rat airways in vivo. Regul Pept 2004 117: 149 154.
96. Onoue S, Yamada S, Yajima T. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Peptides 2007 28: 1640 1650.
97. Groneberg DA, Rabe KF, Fischer A. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol 2006 533: 182 194.
98. Gonzalez-Rey E, Delgado M. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders? Trends Pharmacol Sci 2007 28: 482 491.
99. Ohbayashi H, Suito H, Yoshida N, Ilto Y, Kume H, Yamaki K. Adrenomedullin inhibits ovalbumin-induced bronchoconstriction and airway microvascular leakage in guinea-pigs. Eur Respir J 1999 14: 1076 1081.
100. Yamamoto H, Nagase T, Shindo T, Teramoto S, Oki-Nagase T, Yamaguchi Y et al. Adrenomedullin insufficiency increases allergen-induced airway hyperresponsiveness in mice. J Appl Physiol 2007 102: 2361 2368.
101. Mohapatra SS, Lockey RF, Vesely DL, Gower WR, Jr. Natriuretic peptides and genesis of asthma: an emerging paradigm? J Allergy Clin Immunol 2004 114: 520 526.
102. Angus RM, Millar EA, Chalmers GW, Thomson NC. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP). Thorax 1996 51: 71 74.
103. Van EW, Van der ZR, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005 5: 318 330.
104. Rha YH, Taube C, Haczku A, Joetham A, Takeda K, Duez C et al. Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol 2002 169: 5300 5307.
105. Schleimer RP. Interactions between the hypothalamic-pituitary-adrenal axis and allergic inflammation. J Allergy Clin Immunol 2000 106: S270 S274.
106. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006 6: 772 783.
107. Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy 2007 62: 1205 1213.
108. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006 118: 389 395.
109. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004 109: 2046 2049.
110. Riffo-Vasquez Y, Ligeiro de Oliveira AP, Page CP, Spina D, Tavares-de-Lima W. Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy 2007 37: 459 470.
111. Balzano G, Fuschillo S, Melillo G, Bonini S. Asthma and sex hormones. Allergy 2001 56: 13 20.
112. Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 2007 8: 209 216.
113. Puccetti P, Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 2007 40: 101 105.
114. De Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, Willart MA et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004 200: 89 98.
115. Maneechotesuwan K, Supawita S, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. J Allergy Clin Immunol 2008 121: 43 50.
116. Terness P, Chuang JJ, Opelz G. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol 2006 27: 68 73.
117. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004 114: 997 1008.
118. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001 2: 10 19.
119. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004 4: 617 629.
120. D'Agostino B, Roviezzo F, De PR, Terracciano S, De NM, Gallelli L et al. Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. Clin Exp Allergy 2007 37: 1436 1443.
121. Greenlee KJ, Corry DB, Engler DA, Matsunami RK, Tessier P, Cook RG et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 2006 177: 7312 7321.
122. Walsh GM, Sexton DW, Blaylock MG. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol 2003 178: 37 43.
123. Michallet MC, Saltel F, Flacher M, Revillard JP, Genestier L. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance. J Immunol 2004 172: 5405 5414.
124. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006 533: 222 239.
125. Bowler RP. Oxidative stress in the pathogenesis of asthma. Curr Allergy Asthma Rep 2004 4: 116 122.
126. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999 354: 482 483.
127. Xia ZW, Xu LQ, Zhong WW, Wei JJ, Li NL, Shao J et al. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1. Am J Pathol 2007 171: 1904 1914.
128. Koike Y, Hisada T, Utsugi M, Ishizuka T, Shimizu Y, Ono A et al. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol 2007 37: 322 329.
129. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 2005 202: 47 59.
130. Mathrani VC, Kenyon NJ, Zeki A, Last JA. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide? Curr Med Chem 2007 14: 2204 2213.
131. Chapman JT, Otterbein LE, Elias JA, Choi AM. Carbon monoxide attenuates aeroallergen-induced inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2001 281: L209 L216.
132. Ryter SW, Choi AM. Therapeutic applications of carbon monoxide in lung disease. Curr Opin Pharmacol 2006 6: 257 262.
133. Beier KC, Kallinich T, Hamelmann E. Master switches of T-cell activation and differentiation. Eur Respir J 2007 29: 804 812.
134. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006 12: 574 579.
135. Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002 122: 171 176.
136. Cho YS, Kwon B, Lee TH, Kim TB, Moon KA, La S et al. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Clin Exp Allergy 2006 36: 377 385.
137. Polte T, Foell J, Werner C, Hoymann HG, Braun A, Burdach S et al. CD137-mediated immunotherapy for allergic asthma. J Clin Invest 2006 116: 1025 1036.
138. Tong J, Bandulwala HS, Clay BS, Anders RA, Shilling RA, Balachandran DD et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med 2006 203: 1173 1184.
139. Melis M, Siena L, Pace E, Gjomarkaj M, Profita M, Pirazzoli A et al. Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects. Eur Respir J 2002 19: 257 266.
140. Katz HR. Inhibitory receptors and allergy. Curr Opin Immunol 2002 14: 698 704.
141. Norris HH, Peterson ME, Stebbins CC, McConchie BW, Bundoc VG, Trivedi S et al. Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation. J Leukoc Biol 2007 82: 1531 1541.
142. Wang JY, Reid KB. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 2007 212: 417 425.
143. Kohl J, Baelder R, Lewkowich IP, Pandey MK, Hawlisch H, Wang L et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 2006 116: 783 796.
144. Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 2005 365: 167 175.
145. Xu J, Park PW, Kheradmand F, Corry DB. Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol 2005 174: 5758 5765.
146. Culley FJ, Fadlon EJ, Kirchem A, Williams TJ, Jose PJ, Pease JE. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur J Immunol 2003 33: 1302 1310.
147. Diamant Z, Timmers MC, van der Veen H, Page CP, van der Meer FJ, Sterk PJ. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med 1996 153: 1790 1795.
148. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005 142: 481 489.
149. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001 22: 199 204.
150. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007 119: 1313 1320.